Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.88EUR
−17.68 MEUR
9.29 M
About Imunon, Inc.
Sector
Industry
CEO
Stacy R. Lindborg
Website
Headquarters
Lawrenceville
Employees (FY)
33
Founded
1982
FIGI
BBG000N10RK9
Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm is also engaged in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CBO is 1.34 EUR — it has decreased by 0.74% in the past 24 hours. Watch IMUNON INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange IMUNON INC stocks are traded under the ticker CBO.
CBO stock has fallen by 0.74% compared to the previous week, the month change is a 4.69% rise, over the last year IMUNON INC has showed a 19.64% increase.
We've gathered analysts' opinions on IMUNON INC future price: according to them, CBO price has a max estimate of 11.04 EUR and a min estimate of 7.36 EUR. Watch CBO chart and read a more detailed IMUNON INC stock forecast: see what analysts think of IMUNON INC and suggest that you do with its stocks.
CBO stock is 0.75% volatile and has beta coefficient of 1.77. Track IMUNON INC stock price on the chart and check out the list of the most volatile stocks — is IMUNON INC there?
Today IMUNON INC has the market capitalization of 12.50 M, it has increased by 2.16% over the last week.
Yes, you can track IMUNON INC financials in yearly and quarterly reports right on TradingView.
IMUNON INC is going to release the next earnings report on Aug 14, 2024. Keep track of upcoming events with our Earnings Calendar.
CBO earnings for the last quarter are −0.48 EUR per share, whereas the estimation was −0.53 EUR resulting in a 8.24% surprise. The estimated earnings for the next quarter are −0.51 EUR per share. See more details about IMUNON INC earnings.
IMUNON INC revenue for the last quarter amounts to 0 EUR despite the estimated figure of 0 EUR. In the next quarter revenue is expected to reach 0 EUR.
CBO net income for the last quarter is −4.57 M EUR, while the quarter before that showed −4.43 M EUR of net income which accounts for −3.16% change. Track more IMUNON INC financial stats to get the full picture.
No, CBO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 2, 2024, the company has 33.00 employees. See our rating of the largest employees — is IMUNON INC on this list?
Like other stocks, CBO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMUNON INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IMUNON INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IMUNON INC stock shows the buy signal. See more of IMUNON INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.